---
title: "CISEN released its performance for the first three quarters, with a net profit attributable to the parent company of 382 million yuan, a year-on-year decrease of 4.05%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/263032428.md"
description: "According to the Zhitong Finance APP, CISEN disclosed its third-quarter report for 2025. The company achieved revenue of 2.584 billion yuan in the first three quarters, a year-on-year decrease of 13.94%; the net profit attributable to the parent company was 382 million yuan, a year-on-year decrease of 4.05%; the net profit excluding non-recurring gains and losses was 274 million yuan, a year-on-year decrease of 24.60%; the basic earnings per share were 0.84 yuan"
datetime: "2025-10-28T08:34:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263032428.md)
  - [en](https://longbridge.com/en/news/263032428.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263032428.md)
---

# CISEN released its performance for the first three quarters, with a net profit attributable to the parent company of 382 million yuan, a year-on-year decrease of 4.05%

According to the Zhitong Finance APP, CISEN (603367.SH) disclosed its third-quarter report for 2025. The company achieved a revenue of 2.584 billion yuan in the first three quarters, a year-on-year decrease of 13.94%; the net profit attributable to shareholders was 382 million yuan, a year-on-year decrease of 4.05%; the net profit excluding non-recurring items was 274 million yuan, a year-on-year decrease of 24.60%; the basic earnings per share were 0.84 yuan

### Related Stocks

- [603367.CN](https://longbridge.com/en/quote/603367.CN.md)

## Related News & Research

- [Lytix Biopharma Advances Ruxotemitide Program as Q1 2026 Results Underscore Oncology Focus](https://longbridge.com/en/news/287162474.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [Blake Lively faces $2.1M contractor debt after Baldoni settlement](https://longbridge.com/en/news/287065402.md)
- [HSA warns public against consuming herbal remedy containing potent steroid](https://longbridge.com/en/news/287022845.md)
- [Indonesia’s investment app Pluang raises $10M, expands into equities marketGrows**](https://longbridge.com/en/news/286855201.md)